Elsevier

Brain Research

Volume 568, Issues 1–2, 24 December 1991, Pages 205-214
Brain Research

Chronicl-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance

https://doi.org/10.1016/0006-8993(91)91399-LGet rights and content

Abstract

Two separate experiments were conducted to assess the behavioral and biochemical effects of chronicl-dihydroxyphenylalanine (l-DOPA) treatment in rats with unilateral 6-hydroxydopamine (6-OHDA) lesions. In this animal model, contralateral rotation provides the behavioral indicator response forl-DOPA activation of the dopamine denervated striatum. Following 30 dailyl-DOPA treatments, a subthreshold dose (10 mg/kg) for rotation became suprathreshold and the contralateral rotation induced by a suprathreshold dose (20 mg/kg) became exaggerated. This motoric sensitization tol-DOPA was not reversed by a three-day period ofl-DOPA withdrawal. In contrast with the emergence of behavioral sensitization tol-DOPA, biochemical measurements showed that the increase of dopamine metabolite concentrations (DOPAC and HVA) induced by acutel-DOPA treatment became attenuated with chronic treatment. This finding suggests that chronicl-DOPA treatment produces a partial tolerance in the conversion ofl-DOPA to extracellular dopamine. The emergence ofl-DOPA sensitization-overstimulation effects was hypothesized to reflect the combined effects of dopamine receptor priming and Pavlovian drug conditioning and to contribute to the emergence of dyskinetic effects ofl-DOPA therapy. The partial tolerance observed for dopamine metabolites was hypothesized to represent a decreased conversion ofl-DOPA to dopamine which with long-term treatment could progress to an eventual wearing-off effect ofl-DOPA therapy.

Reference (42)

  • MorelliM. et al.

    Time and dose-dependence of the ‘priming’ of the expression of dopamine receptor supersensitivity

    Eur. J. Pharmacol.

    (1989)
  • OlneyJ.W. et al.

    Excitotoxicity ofl-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's disease

    Exp. Neurol.

    (1990)
  • SchwartingR. et al.

    Short-term effects of ether, equithesin, and droperidol/fentanyl on catecholamine and indoleamine metabolism in the brain in the rat

    Neuropharmacology

    (1987)
  • ZetterstromT. et al.

    Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis

    Brain Research

    (1986)
  • AchesonA.L. et al.

    Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons

    J. Neurosci.

    (1981)
  • BaldessariniR.J.

    Dopamine and the pathophysiology of dyskenesias induced by antipsychotic drugs

    Annu. Rev. Neurosci.

    (1980)
  • BanT.A.

    Pharmacology of schizophrenia

    Curr. Psych. Ther.

    (1976)
  • CalneD.B. et al.

    Dopamine agonists and Parkinson's disease

    Can. J. Neurol. Sci.

    (1984)
  • Carey, R.J., Conditioning ofl-DOPA induced movement, Psychopharmacology, in...
  • CareyR.J.

    l-DOPA accumulates selectively in the dopamine depleted striatum following chronic treatment

    Abstr. Soc. Neurosci.

    (1990)
  • Cited by (84)

    • The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N<sup>G</sup>-nitro-l-arginine methyl ester administered alone or jointly with l-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats

      2015, Brain Research
      Citation Excerpt :

      Assuming the hypofunction of the nitrergic system in 6-OHDA-lesioned rats, in our recently published study we have demonstrated that chronic combined administration of a low dose of the NO donor molsidomine (2 mg/kg) jointly with the widely used antiparkinsonian drug L-3,4-dihydroxyphenylalanine (l-DOPA; 25 mg/kg) caused a slight but significant decrease in the number of contralateral rotations and a marked enhancement in a tissue concentrations of l-DOPA-derived DA in the STR and SN when compared to the values of these parameters in rats treated chronically with l-DOPA alone (Lorenc-Koci et al., 2013). The rotational behavior after l-DOPA is commonly used as an indicator of antiparkinsonian function of potential novel drugs but also it is considered to be a measure of dyskinesiogenic liability (Carey, 1991; Henry et al., 1998; Lane et al., 2006). In our study rotational behavior after l-DOPA was slightly reduced in the presence of molsidomine, therefore the obtained result could be interpreted as a modulation of dopaminergic response but also as a potential antidyskinetic effect (Lorenc-Koci et al., 2013).

    • Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra

      2014, Behavioural Brain Research
      Citation Excerpt :

      The number of rotations increased with elapsing time and reached a plateau after one-week treatment. These results are in accordance with well-documented findings that repeated l-DOPA treatment is accompanied by a marked enhancement in rotational response [30,31,33,36,49]. A single “priming” administration of apomorphine which we used to determine the extent of lesion one week before the first dose of l-DOPA could further enhance the rotational response elicited by l-DOPA by induction of sensitization phenomenon.

    • Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats

      2013, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Since its development several decades ago, the 6-hydroxydopamine (6-OHDA) rat model of PD has served as a valuable means to explore the consequences of dopamine depletion on motor behavior (Ungerstedt and Arbuthnott, 1970). In this model, rats receive a unilateral stereotaxic injection with the neurotoxin 6-OHDA to selectively destroy dopaminergic neurons, resulting in dopamine agonist-mediated motor behavior, in which the animals rotate contralateral to the dopamine-denervated striatum (Carey, 1991). Numerous studies have demonstrated that 6-OHDA rats treated with D1, D2, or D1/D2 dopamine agonists display a behavioral sensitization phenomenon known as “priming” or “reverse tolerance” such that repeated administration of the same dose of dopamine agonist produces contralateral rotational behavior of increasing magnitude (Asin et al., 1995; Carey, 1991; Gancher and Mayer, 1995; Paul et al., 1995; Pinheiro-Carrera et al., 1994; Pollack et al., 1997; Rouillard et al., 1987).

    View all citing articles on Scopus
    View full text